Geographic Atrophy of the Macula
2 clinical trials · Condition
◉ Watch Geographic Atrophy of the Macula
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD (NCT06659549) | Galimedix Therapeutics Inc | 2025-01-10 |
| A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (NCT05839041) | Aviceda Therapeutics, Inc. | 2023-05-02 |
Track Geographic Atrophy of the Macula automatically
Every clearance here is in the API, with alerts when new ones post.